報告摘要

The Global Biocatalysts and Enzyme Engineering Market was valued at USD 3,181.31 million in 2025 and is projected to reach USD 5,631.87 million by 2035. The market is expected to expand at a CAGR of 5.88% during the forecast period, driven by increasing demand for sustainable and efficient bioprocessing solutions. Growing Demand from the Pharmaceutical and Biopharmaceutical Industries Drives Market Growth The expanding pharmaceutical and biopharmaceutical sectors are the primary drivers of the global biocatalysts and enzyme engineering market, as enzyme-based technologies enable the precise, efficient, and cost-effective production of complex drug molecules. Rising demand for biologics, gene therapies, and personalized medicines is further accelerating the adoption of advanced enzyme engineering solutions. Market Segmentation Overview By Product Type • Enzymes: Widely used for efficient and precise biocatalytic reactions. • Co-Enzyme: Supports enzyme activity in complex biochemical processes. By Application • Pharmaceutical Manufacturing: Enables cost-effective production of high-purity pharmaceutical compounds. • Synthetic Biology and Metabolic Engineering: Facilitates engineered biological pathways for advanced bioprocesses. • Diagnostic: Enhances accuracy and reliability of diagnostic testing methods. • Others: Supports diverse industrial and research-based biological applications. By End User • Pharmaceutical and Biopharmaceutical Companies: Major adopters for innovative drug development processes. • CROs and CDMOs: Offer specialized enzyme-based research and manufacturing services. • Diagnostics and Clinical Laboratories: Utilize enzymes for accurate clinical testing applications. • Others: Includes academic institutes and industrial research organizations. Regional Analysis North America and Europe lead the global biocatalysts and enzyme engineering market with strong research capabilities, established biotechnology industries, and advanced manufacturing infrastructure. Meanwhile, Asia Pacific is witnessing the fastest growth, while South America and the Middle East & Africa are steadily expanding through rising pharmaceutical investments and increasing adoption of sustainable bioprocessing technologies. Strategic Collaboration for siRNA Manufacturing March 2026 – CODEXIS: Codexis entered into a strategic agreement with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA (siRNA) using its proprietary ECO Synthesis platform. The collaboration supports preclinical development of a cardiovascular therapeutic candidate while reinforcing the company's leadership in scalable enzymatic manufacturing solutions. Strategic Edge: Strengthening Innovation Through Academic Partnerships Collaborations between biocatalyst companies and universities are creating significant opportunities to accelerate enzyme discovery and next-generation biocatalyst development. By leveraging advanced research expertise, specialized facilities, and scientific innovation, companies can develop high-performance enzyme solutions while reducing research costs and time-to-market. Key Report Attributes • Market Size 2025: USD 3,181.31 Million • Market Size 2035: USD 5,631.87 Million • CAGR (2025-2035): 5.88% • Base Year: 2024 • Market Forecast Period: 2025-2035 Industry Segmentations Growth • By Product Type: Enzymes - 6.04%, Co- Enzyme - 5.10%. • By Application: Pharmaceutical Manufacturing - 5.44%, Synthetic Biology and Metabolic Engineering - 7.15%. • By End User: Pharmaceutical and Biopharmaceutical Companies - 5.44%, CROs and CDMOs - 7.15%.

目錄 Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ........... 17 2 MARKET INTRODUCTION ........ 19 2.1 DEFINITION ...................... 19 2.2 SCOPE OF THE STUDY ...................... 19 2.3 RESEARCH OBJECTIVE .................... 19 2.4 MARKET STRUCTURE ...................... 20 3 RESEARCH METHODOLOGY ...................... 21 3.1 OVERVIEW .... 21 3.2 DATA FLOW ...................... 23 3.2.1 DATA MINING PROCESS ......... 23 3.3 PURCHASED DATABASE: ................. 24 3.4 SECONDARY SOURCES: .................... 25 3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 26 3.5 PRIMARY RESEARCH: ... 27 3.5.1 PRIMARY RESEARCH DATA FLOW: ............. 28 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ............. 29 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........... 30 3.6.1 REVENUE ANALYSIS APPROACH ................. 30 3.7 DATA FORECASTING..... 31 3.7.1 DATA FORECASTING TYPE ...... 31 3.8 DATA MODELING ............ 32 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 32 3.8.2 DATA MODELING: ................... 33 3.9 TEAMS AND ANALYST CONTRIBUTION ....... 35 4 MARKET DYNAMICS ................ 37 4.1 MARKET TRENDS IN GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING ................ 37 4.1.1 SHIFT TOWARD GREEN AND SUSTAINABLE CHEMISTRY ...................... 37 4.1.2 ADVANCEMENTS IN ENZYME ENGINEERING TECHNOLOGIES ............... 37 4.1.3 INCREASING USE IN PHARMACEUTICAL MANUFACTURING .................. 37 4.2 DRIVERS ......... 38 4.2.1 INCREASING DEMAND FOR GREEN TECHNOLOGIES ......... 38 4.2.2 RISING HEALTHCARE COSTS ...................... 39 4.2.3 GROWING DEMAND FROM PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES ...................... 39 4.3 RESTRAINTS .................... 39 4.3.1 HIGH PRODUCTION COSTS ..... 39 4.3.2 REGULATORY CHALLENGES .... 40 4.3.3 ENZYME STABILITY AND OPERATIONAL LIMITATIONS .... 40 4.4 OPPORTUNITIES ............. 41 4.4.1 EXPANSION INTO EMERGING MARKETS ...... 41 4.4.2 PARTNERSHIPS WITH ACADEMIC INSTITUTIONS ............. 41 5 MARKET FACTOR ANALYSIS ...................... 43 5.1 PESTLE ANALYSIS ......... 43 5.1.1 POLITICAL FACTORS .............. 43 5.1.2 ECONOMIC FACTORS ............. 43 5.1.3 SOCIAL FACTORS ................... 43 5.1.4 TECHNOLOGICAL FACTORS .... 44 5.1.5 LEGAL FACTOR ...................... 44 5.1.6 ENVIRONMENTAL FACTORS ... 44 5.2 PORTER'S FIVE FORCES MODEL ... 45 5.2.1 THREAT OF NEW ENTRANTS ... 45 5.2.2 BARGAINING POWER OF SUPPLIERS ........... 46 5.2.3 THREAT OF SUBSTITUTES ...... 46 5.2.4 BARGAINING POWER OF BUYERS ................ 46 5.2.5 INTENSITY OF RIVALRY .......... 47 5.3 REGULATORY ENVIRONMENT & COMPLIANCE ............. 47 5.3.1 OVERVIEW OF REGULATORY FRAMEWORK ...................... 47 5.3.2 PHARMACEUTICAL AND BIOTECHNOLOGY APPLICATIONS .................. 47 5.4 TECHNOLOGICAL TRENDS .............. 48 5.4.1 PROTEIN ENGINEERING AND DIRECTED EVOLUTION ........ 48 5.4.2 SYNTHETIC BIOLOGY AND PATHWAY ENGINEERING........ 48 5.5 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS ...................... 48 5.6 PARTNERSHIPS & COLLABORATIONS ............ 49 5.6.1 ENZYME TECHNOLOGY ALLIANCE ADDS BIO-PRODICT .... 49 5.6.2 ACIES BIO AND PROTEIN EVOLUTION PARTNERSHIP ....... 49 5.6.3 AMINOVERSE AND PROZOMIX STRATEGIC COLLABORATION ............... 49 6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE ............. 51 6.1 OVERVIEW .... 51 6.2 ENZYME ......... 53 6.2.1 KETOREDUCTASE ................... 53 6.2.2 LACTATE DEHYDROGENASE ... 53 6.2.3 FORMATE DEHYDROGENASE ...................... 53 6.2.4 GLUCOSE DEHYDROGENASE ... 53 6.2.5 D-AMINO ACID DEHYDROGENASE ............... 53 6.2.6 NITRO REDUCTASE ................. 54 6.2.7 MONOAMINE OXIDASE ........... 54 6.2.8 NITRILASE .......... 54 6.2.9 AMIDASE ........... 54 6.2.10 NITRILE REDUCTASE............... 54 6.2.11 ALCOHOL OXIDASE ................ 54 6.2.12 GALACTOSE OXIDASE ............. 54 6.2.13 Ω-TRANSAMINASES (ATA) ...... 54 6.2.14 ALDOLASE ......... 55 6.2.15 PROTEASE ......... 55 6.2.16 LIPASE ............... 55 6.2.17 OTHERS ............. 55 6.3 CO-ENZYMES ................... 55 6.3.1 NAD⁺ / NADH ..... 55 6.3.2 NADP⁺ / NADPH ..................... 56 6.3.3 NMN .................. 56 6.3.4 FAD / FMN ......... 56 6.3.5 OTHERS ............. 56 7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION ................. 57 7.1 OVERVIEW .... 57 7.2 PHARMACEUTICALS MANUFACTURING ..... 58 7.3 SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING .................. 58 7.4 DIAGNOSTIC ..................... 59 7.5 OTHERS .......... 59 8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER ...................... 61 8.1 OVERVIEW .... 61 8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ... 62 8.3 CROS AND CDMOS .......... 62 8.4 DIAGNOSTICS AND CLINICAL LABORATORIES ............... 63 8.5 OTHERS .......... 63 9 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY REGION ....... 65 9.1 OVERVIEW .... 65 9.2 NORTH AMERICA ........... 66 9.2.1 US...................... 70 9.2.2 CANADA ............ 73 9.3 EUROPE .......... 75 9.3.1 GERMANY .......... 79 9.3.2 FRANCE ............. 81 9.3.3 UK ..................... 83 9.3.4 ITALY ................. 85 9.3.5 SPAIN ................ 87 9.3.6 RUSSIA .............. 88 9.3.7 REST OF EUROPE .................... 91 9.4 ASIA-PACIFIC ................... 93 9.4.1 CHINA ................ 97 9.4.2 INDIA ................. 99 9.4.3 JAPAN ............... 101 9.4.4 SOUTH KOREA .... 103 9.4.5 MALAYSIA ......... 105 9.4.6 THAILAND .......... 107 9.4.7 INDONESIA ......... 109 9.4.8 REST OF ASIA-PACIFIC ........... 111 9.5 LATIN AMERICA ............. 113 9.5.1 MEXICO ............. 117 9.5.2 BRAZIL ............... 119 9.5.3 ARGENTINA ....... 121 9.5.4 REST OF LATAM ..................... 123 9.6 MIDDLE EAST & AFRICA .................. 125 9.6.1 GCC ................... 129 9.6.2 SOUTH AFRICA ... 131 9.6.3 REST OF MEA ..... 133 10 COMPETITIVE LANDSCAPE .... 136 10.1 INTRODUCTION ............... 136 10.2 MARKET SHARE ANALYSIS, 2025 ................... 137 10.3 COMPETITOR DASHBOARD............. 138 10.4 PUBLIC PLAYERS STOCK SUMMARY ............. 139 10.4.1 PUBLIC PLAYERS STOCK SUMMARY ........... 139 10.4.2 PUBLIC PLAYERS STOCK SUMMARY ........... 139 10.4.3 PUBLIC PLAYERS STOCK SUMMARY ........... 139 10.4.4 PUBLIC PLAYERS STOCK SUMMARY ........... 139 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES ............ 140 10.5.1 EVALUATION ...... 140 11 COMPANY PROFILES .............. 141 11.1 NOVONESIS ... 141 11.1.1 COMPANY OVERVIEW ............ 141 11.1.2 FINANCIAL OVERVIEW ............ 142 11.1.3 PRODUCTS OFFERED .............. 142 11.1.4 KEY DEVELOPMENTS .............. 143 11.1.5 SWOT ANALYSIS .................... 144 11.1.6 KEY STRATEGIES .................... 144 11.2 CODEXIS, INC. ................... 145 11.2.1 COMPANY OVERVIEW ............ 145 11.2.2 FINANCIAL OVERVIEW ............ 146 11.2.3 PRODUCTS OFFERED .............. 147 11.2.4 KEY DEVELOPMENTS .............. 147 11.2.5 KEY STRATEGIES .................... 147 11.3 BIOCATALYSTS LTD ...... 149 11.3.1 COMPANY OVERVIEW ............. 149 11.3.2 FINANCIAL OVERVIEW ............ 150 11.3.3 PRODUCTS OFFERED .............. 150 11.3.4 KEY DEVELOPMENTS .............. 150 11.3.5 SWOT ANALYSIS .................... 151 11.3.6 KEY STRATEGIES .................... 151 11.4 AMANO ENZYME INC. ...................... 153 11.4.1 COMPANY OVERVIEW ............. 153 11.4.2 FINANCIAL OVERVIEW ............ 154 11.4.3 PRODUCTS OFFERED .............. 154 11.4.4 SWOT ANALYSIS .................... 155 11.4.5 KEY DEVELOPMENTS .............. 155 11.4.6 KEY STRATEGY ... 155 11.5 INFINITA ....... 157 11.5.1 COMPANY OVERVIEW ............ 157 11.5.2 FINANCIAL OVERVIEW ............ 157 11.5.3 PRODUCTS OFFERED .............. 157 11.5.4 KEY DEVELOPMENTS .............. 159 11.5.5 KEY STRATEGIES .................... 159 11.6 ADVANCED ENZYMES ...................... 160 11.6.2 FINANCIAL OVERVIEW ............ 160 11.6.4 KEY DEVELOPMENTS .............. 162 11.6.5 SWOT ANALYSIS .................... 162 11.7 CREATIVE ENZYMES .... 164 11.7.1 COMPANY OVERVIEW ............. 164 11.7.2 FINANCIAL OVERVIEW ............ 164 11.7.3 PRODUCTS OFFERED .............. 165 11.7.4 KEY DEVELOPMENTS .............. 165 11.7.5 SWOT ANALYSIS .................... 165 11.7.6 KEY STRATEGIES .................... 166 11.8 ASYMCHEM...................... 167 11.8.1 COMPANY OVERVIEW ............. 167 11.8.2 FINANCIAL OVERVIEW ............ 168 11.8.3 PRODUCTS OFFERED .............. 169 11.8.4 SWOT ANALYSIS .................... 169 11.8.5 KEY STRATEGIES .................... 169 11.9 ALMAC ........... 171 11.9.2 FINANCIAL OVERVIEW ............ 172 11.9.4 KEY DEVELOPMENTS .............. 173 11.9.5 SWOT ANALYSIS .................... 174 11.10 ENGINZYME ..................... 175 11.10.1 COMPANY OVERVIEW ............. 175 11.10.2 PRODUCTS OFFERED .............. 176 11.10.3 KEY DEVELOPMENTS .............. 176 11.10.4 KEY STRATEGIES .................... 176 12 DATA CITATIONS ..................... 178

圖表清單 List of Tables & Figures

LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 34 TABLE 2 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019–2035 (USD MILLION) 52 TABLE 3 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 57 TABLE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019–2035 (USD MILLION) 62 TABLE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY REGION, 2019-2035 (USD MILLION) 65 TABLE 6 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 67 TABLE 7 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 68 TABLE 8 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 69 TABLE 9 NORTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 70 TABLE 10 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 70 TABLE 11 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 71 TABLE 12 US: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 72 TABLE 13 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 73 TABLE 14 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 74 TABLE 15 CANADA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 74 TABLE 16 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 76 TABLE 17 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 77 TABLE 18 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 78 TABLE 19 EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 79 TABLE 20 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 79 TABLE 21 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80 TABLE 22 GERMANY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 81 TABLE 23 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 81 TABLE 24 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 82 TABLE 25 FRANCE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 82 TABLE 26 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 83 TABLE 27 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84 TABLE 28 UK: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 84 TABLE 29 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 85 TABLE 30 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 86 TABLE 31 ITALY: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 86 TABLE 32 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 87 TABLE 33 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 88 TABLE 34 SPAIN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 88 TABLE 35 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 89 TABLE 36 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 90 TABLE 37 RUSSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 90 TABLE 38 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 91 TABLE 39 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 92 TABLE 40 REST OF EUROPE: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 92 TABLE 41 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 94 TABLE 42 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 95 TABLE 43 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 96 TABLE 44 ASIA PACIFIC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 96 TABLE 45 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 97 TABLE 46 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 98 TABLE 47 CHINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 98 TABLE 48 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 99 TABLE 49 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 100 TABLE 50 INDIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 100 TABLE 51 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 101 TABLE 52 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 102 TABLE 53 JAPAN: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 102 TABLE 54 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 103 TABLE 55 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 104 TABLE 56 SOUTH KOREA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 104 TABLE 57 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 105 TABLE 58 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 106 TABLE 59 MALAYSIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 106 TABLE 60 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 107 TABLE 61 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 108 TABLE 62 THAILAND: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 108 TABLE 63 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 109 TABLE 64 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 110 TABLE 65 INDONESIA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 110 TABLE 66 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 111 TABLE 67 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 112 TABLE 68 REST OF APAC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 113 TABLE 69 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 114 TABLE 70 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 115 TABLE 71 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 116 TABLE 72 SOUTH AMERICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 116 TABLE 73 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 117 TABLE 74 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 118 TABLE 75 MEXICO: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 118 TABLE 76 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 119 TABLE 77 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 120 TABLE 78 BRAZIL: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 120 TABLE 79 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 121 TABLE 80 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 122 TABLE 81 ARGENTINA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 122 TABLE 82 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 123 TABLE 83 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 124 TABLE 84 REST OF LATAM: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 124 TABLE 85 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 126 TABLE 86 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 127 TABLE 87 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 128 TABLE 88 MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 128 TABLE 89 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 129 TABLE 90 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 130 TABLE 91 GCC: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 130 TABLE 92 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 131 TABLE 93 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 132 TABLE 94 SOUTH AFRICA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 132 TABLE 95 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 133 TABLE 96 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 134 TABLE 97 REST OF MEA: BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY END USER, 2019-2035 (USD MILLION) 134 TABLE 98 EVALUATION 140 TABLE 99 NOVONESIS: PRODUCTS OFFERED 142 TABLE 100 CODEXIS INC.: PRODUCT OFFERED 147 TABLE 101 BIOCATALYSTS: PRODUCT OFFERED 150 TABLE 102 AMANO ENZYME INC.: PRODUCTS OFFERED 154 TABLE 103 INFINITA: PRODUCTS OFFERED 157 TABLE 105 CREATIVE ENZYMES: PRODUCTS OFFERED 165 TABLE 106 ASYMCHEM: PRODUCTS OFFERED 169 TABLE 108 ENGINZYME: PRODUCTS OFFERED 176 LIST OF FIGURES FIGURE 1 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET: STRUCTURE FIGURE 2 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 38 FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET FIGURE 4 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS FIGURE 5 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY PRODUCT TYPE, 2025 FIGURE 6 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY PRODUCT TYPE, ATTRACTIVENESS ANALYSIS FIGURE 7 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY APPLICATION, 2024 FIGURE 8 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET, BY APPLICATION, ATTRACTIVENESS ANALYSIS FIGURE 9 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY END USER, 2024 FIGURE 10 GLOBAL BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY REGION, 2025 FIGURE 11 NORTH AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION) FIGURE 12 NORTH AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025 FIGURE 13 EUROPE MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION) FIGURE 14 EUROPE BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2025 FIGURE 15 ASIA-PACIFIC MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION) FIGURE 16 ASIA-PACIFIC BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024 FIGURE 17 LATIN AMERICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION) FIGURE 18 LATIN AMERICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024 FIGURE 19 MIDDLE EAST & AFRICA MARKET ANALYSIS: BIOCATALYSTS & ENZYME ENGINEERING MARKET, 2019-2035 (USD MILLION) FIGURE 20 MIDDLE EAST & AFRICA BIOCATALYSTS & ENZYME ENGINEERING MARKET SHARE (%), BY COUNTRY, 2024 FIGURE 21 GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 FIGURE 22 COMPETITOR DASHBOARD: GLOBAL BIOCATALYSTS AND ENZYME ENGINEERING MARKET FIGURE 23 NOVONESIS: SWOT ANALYSIS FIGURE 24 BIOCATALYSTS LTD.: SWOT ANALYSIS FIGURE 25 AMANO ENZYME INC.: SWOT ANALYSIS FIGURE 26 ADVANCED ENZYMES: SWOT ANALYSIS FIGURE 27 CREATIVE ENZYMES: SWOT ANALYSIS FIGURE 28 ASYMCHEM: SWOT ANALYSIS FIGURE 29 ALMAC: SWOT ANALYSIS

Single User Price	$4,950 USD
Multi User Licence (up to 10 users)	$5,950 USD
Enterprisewide Price (Global Site License)	$7,250 USD

授權報價

報告摘要

提及公司

同分類最新報告（醫療與生命科學）